Letter to the Editor: "Docetaxel and its nanoformulations: how delivery strategies could impact the therapeutic outcome?"

Ther Deliv. 2021 May;12(5):343-344. doi: 10.4155/tde-2020-0120. Epub 2021 Mar 29.
No abstract available

Keywords: NDLS; docetaxel; nanoparticle; nanosomal docetaxel lipid suspension.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents*
  • Docetaxel
  • Drug Carriers
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Docetaxel